Cellular & Molecular Biology Letters
International Scientific Journal
Established 1996
Volume 14 (2009) No. 4
| DOI: 10.2478/s11658-009-0017-1 Volume 14 (2009) pp 537-547 |
| Title |
THE FUNCTIONAL ANTAGONIST MET-RANTES: A MODIFIED
AGONIST THAT INDUCES DIFFERENTIAL CCR5 TRAFFICKING |
| Authors |
Debra L. Kiss§, James Longden§, Gregory A. Fechner
and Vicky M. Avery* |
| Abstract |
CC chemokine receptor 5 (CCR5) is a pro-inflammatory chemokine
receptor that is expressed on cells of the immune system, and specializes in cell
migration in response to inflammation and tissue damage. Due to its key role in
cell communication and migration, this receptor is involved in various
inflammatory and autoimmune diseases, in addition to HIV infection. Met-
RANTES is a modified CCR5 ligand that has previously been shown to
antagonize CCR5 activation and function in response to its natural ligands in
vitro. In vivo, Met-RANTES is able to reduce inflammation in models of
induced inflammatory and autoimmune diseases. However, due to the fact that
Met-RANTES is also capable of partial agonist activity regarding receptor
signaling and internalization, it is clear that Met-RANTES does not function as
a conventional receptor antagonist. To further elucidate the effect of
Met-RANTES on CCR5, receptor trafficking was investigated in a CHO-CCR5-
GFP cell line using the Opera confocal plate reader. The internalization response
of CCR5 was quantified, and showed that Met-RANTES internalized CCR5 in
a slower, less potent manner than the agonists CCL3 and CCL5. Fluorescent
organelle labeling and live cell imaging showed CCL3 and CCL5 caused CCR5 to traffic through sorting endosomes, recycling endosomes and the Golgi
apparatus. In contrast, Met-RANTES caused CCR5 to traffic through sorting
endosomes and the Golgi apparatus in a manner that was independent of
recycling endosomes. As receptor trafficking impacts on cell surface expression
and the ability of the receptor to respond to more ligand, this information may
indicate an alternative regulation of CCR5 by Met-RANTES that allows the
modified ligand to reduce inflammation through stimulation of a pro-
inflammatory receptor. |
| Keywords |
Met-RANTES, CCR5 trafficking, CCR5 internalization |
| Adress and Contact Informations |
Discovery Biology, Eskitis Institute for Cell and Molecular Therapies,
Brisbane Innovation Park, Griffith University, Don Young Road, Nathan, QLD,
4111, Australia
§Contributed equally
*Author for correspondence. e-mail: v.avery@griffith.edu.au, tel.: +061 737 356056,
fax: +061 737 356001 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0020-6 Volume 14 (2009) pp 548-574 |
| Title |
THE TRANSCRIPTIONAL REGULATION AND CELL-SPECIFIC
EXPRESSION OF THE MAPK-ACTIVATED PROTEIN KINASE MK5 |
| Authors |
Nancy Gerits, Alexey Shiryaev, Sergiy Kostenko, Helle
Klenow, Olga Shiryaeva, Mona Johannessen and Ugo Moens*
|
| Abstract |
The mitogen-activated protein kinase (MAPK) cascades regulate
important cellular processes, including growth, differentiation, apoptosis,
embryogenesis, motility and gene expression. Although MAPKs mostly appear
to be constitutively expressed, the transcript levels of some MAPK-encoding
genes increase upon treatment with specific stimuli. This applies to the MAPK-
activated protein kinases MK2 and MK3. By contrast, the transcriptional
regulation of the related MK5 has not yet been studied. The MK5 promoters of
mouse, rat and human contain a plethora of putative transcription factor sites,
and the spatio-temporal expression of MK5 suggests inducible transcription of
the gene. We examined the transcription pattern of MK5 in different tissues, and
studied the kinetics of MK5 expression at the transcriptional and/or translation
level in PC12 cells exposed to arsenite, forskolin, KCl, lipopolysaccharide,
spermine NONOate, retinoic acid, serum, phorbol ester, temperature shock, and
vanadate. Cells exposed to forskolin display a transient increase in MK5 mRNA,
despite their unaltered MK5 protein levels. The MK5 promoters of human,
mouse and rat contain a cAMP-responsive element that binds the cAMP-
responsive element-binding protein (CREB) in vitro. Luciferase reporter
constructs containing an 850-base pair human MK5 promoter fragment encompassing the CRE showed a basal activity that was 10-fold higher than the
corresponding construct in which the CRE motif was deleted. siRNA-mediated
depletion of CREB had no effect on the endogenous MK5 protein levels. Several
binding motifs for heat shock factor are dispersed in the mouse and rat promoter,
and temperature shock transiently enhanced the MK5 transcript levels. None of
the other tested stimuli had an effect on the MK5 mRNA or protein levels. Our
results indicate an inducible regulation of MK5 transcription in response to
specific stimuli. However, the MK5 protein levels remained unaffected by all the
stimuli tested. There is still no explanation for the discrepancy between the
increased mRNA and unchanged MK5 protein levels. |
| Keywords |
Mitogen-activated protein kinase-activated protein kinase, MK5,
Promoter, CREB, Heat-shock, Oxidative stress |
| Adress and Contact Informations |
Department of Microbiology and Virology, Faculty of Medicine, University
of Tromsø, N-9037 Tromsø, Norway
* Author for correspondence. e-mail: ugom@fagmed.uit.no, tel.: +47-77644622, fax: +47-
77645350 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0021-5 Volume 14 (2009) pp 575-586 |
| Title |
THE ANTI-APOPTOTIC ACTIVITY OF ALBUMIN FOR
ENDOTHELIUM IS INHIBITED BY ADVANCED GLYCATION END
PRODUCTS RESTRICTING INTRAMOLECULAR MOVEMENT |
| Authors |
Hans Zoellner1*, Salman Siddiqui1, Elizabeth Kelly1 and Heather Medbury2 |
| Abstract |
Human serum albumin (HSA) inhibits endothelial apoptosis in
a highly specific manner. CNBr fragmentation greatly increases the
effectiveness of this activity, suggesting that this type of protection is mediated
by a partially cryptic albumin domain which is transiently exposed by intra-
molecular movement. Advanced glycation end-product (AGE) formation in
HSA greatly reduces its intra-molecular movement. This study aimed to
determine if this inhibits the anti-apoptotic activity of HSA, and if such
inactivation could be reversed by CNBr fragmentation. HSA-AGE was prepared
by incubating HSA with glucose, and assessed using the fructosamine assay,
mass spectrometry, SDS-PAGE and fluorometry. Low levels of AGE in the
HSA had little effect upon its anti-apoptotic activity, but when the levels of AGE
were high and the intra-molecular movement was reduced, endothelial cell
survival was also found to be reduced to levels equivalent to those in cultures
without HSA or serum (p < 0.001). Survival was restored by the inclusion of
native HSA, despite the presence of HSA with high levels of AGE. Also, CNBr
fragmentation of otherwise inactive HSA-AGE restored the anti-apoptotic
activity for endothelium. Apoptosis was confirmed by DNA gel electrophoresis, transmission electron microscopy and fluorescence-activated cell sorting
analysis, and there was no evidence for direct toxicity in the HSA-AGE
preparations. The results are consistent with the proposed role of intra-molecular
movement in exposing the anti-apoptotic domain in HSA for endothelium. The
levels of AGE formation required to inhibit the anti-apoptotic activity of HSA
exceeded those reported for diabetes. Nonetheless, the data from this study
seems to be the first example of reduced protein function due to AGE-restricted
intra-molecular movement. |
| Keywords |
Apoptosis, Cryptic domain, Endothelium, HSA, HSA-AGE |
| Adress and Contact Informations |
1Cellular and Molecular Pathology Research Unit, Department of Oral Pathology and Oral Medicine, Westmead Centre for Oral Health, The University of Sydney, Westmead, NSW 2145, Australia,
2Department of Surgery, Westmead Hospital, Westmead, NSW, 2145, Australia
* Author for correspondence. e-mail: hzoellne@mail.usyd.edu.au, tel.: + 61 2 9845 7892,
fax: +61 2 9893 8671
|
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0023-3 Volume 14 (2009) pp 587-608 |
| Title |
TRANSCRIPTIONAL PROFILES DURING THE DIFFERENTIATION
AND MATURATION OF MONOCYTE-DERIVED DENDRITIC CELLS,
ANALYZED USING FOCUSED MICROARRAYS |
| Authors |
Weixue Zhong1#, Min Fei1#, Yibei Zhu1,2 and Xueguang Zhang1,2* |
| Abstract |
Dendritic cells (DC) are professional antigen-presenting cells capable
of initiating primary immune responses. They have been intensively studied and
are used in both basic immunology research and clinical immunotherapy.
However, the genetic pathways leading to DC differentiation and maturation
remain poorly understood. Using focused microarrays with oligonucletotide
probes for 120 genes encoding co-stimulatory molecules, chemokines,
chemokine receptors, cytokines, cytokine receptors, TLRs, and several other
related molecules, we analyzed the kinetics of gene expression for the overall
differentiation process of monocytes into mature DC. In parallel, we compared
the transcriptional profiles in DC maturation in the presence of LPS, TNF-α or
trimeric CD40L. We found similar transcriptional profiles for early immature
DC and immature DC, respectively generated by culturing monocytes with GM-
CSF and IL-4 for three or six days. We identified sets of common and stimuli-
specific genes, the expression of which changed following stimulation with LPS,
TNF-α or CD40L. A dynamic analysis of the entire DC differentiation and
maturation process showed that some important inflammatory and constitutive
chemokines are transcribed in both immature and mature DC. The correlative
expression kinetics of the gene pairs IL1R1/IL1R2, IL15/IL15RA,
DC-SIGN/ICAM-2 and DC-SIGN/ICAM-3 imply that they all play crucial roles
in mediating DC functions. Thus, our analysis with focused microarrays shed light on the transcriptional kinetics of DC differentiation and maturation, and
this method may also prove useful for identifying novel marker genes involved
in DC functions. |
| Keywords |
Dendritic cells, Monocytes, Microarray, Transcriptional profile |
| Adress and Contact Informations |
1Institute of Biotechnology and Clinical Immunology Research Laboratory
of Jiangsu Province, Soochow University, Suzhou, P.R. China,
2Stem Cell Research Laboratory of Jiangsu Province, Soochow University, Suzhou, P.R. China
#These authors contributed equally to this work.
* Author for correspondence. e-mail: smbxuegz@public1.sz.js.cn, tel/fax: +86 512 6510 4908 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0022-4 Volume 14 (2009) pp 609-621 |
| Title |
THE INFLUENCE OF JNK AND P38 MAPK INHIBITION ON IL-12P40
AND IL-23 PRODUCTION DEPENDING ON IL12B PROMOTER
POLYMORPHISM |
| Authors |
Zlatka Georgieva Dobreva*, Spaska Angelova Stanilova
and Lyuba Dineva Miteva |
| Abstract |
The interleukin-12p40 gene (IL12B) encodes the p40 polypeptide
chain, which, together with p19, composes IL-23. A bi-allelic promoter
polymorphism (IL12Bpro) located at -2703 bp of the transcription initiation site
has been reported to show associations with IL-12p40 production. To elucidate
the dependence of IL-12p40 and IL-23 production on IL12Bpro polymorphism
in relation to MAPK signal transduction pathways, we examined the effect of
JNK and p38 inhibition on the secretion of these cytokines by stimulated
peripheral blood mononuclear cells (PBMC) from healthy donors with 1.1 and
1.2/2.2 IL12Bpro genotypes. Stimulation with LPS and C3bgp resulted in
approximately equal IL-12p40 production from PBMC with the 1.1 and 1.2/2.2
genotypes. The inhibition of JNK and p38 before stimulation significantly
upregulated IL-12p40 production by PBMC with the 1.1 genotype, but did not
influence IL-12p40 production from PBMC with the 1.2/2.2 genotype. Cultures
of PBMC with the 1.1 genotype produced significantly more IL-12p40 than
PBMC with the 1.2/2.2 genotype after stimulation with PHA. Inhibition of p38
kinase upregulated p40 production only in cultures with the 1.1 genotype.
Decreased IL-23 production was observed in C3bgp-stimulated cultures after the
inhibition of p38 regardless of the genotype of the tested cells. We concluded that IL-12p40 and IL-23 expression, which is mediated by the p38 and JNK
intracellular signaling pathways, is influenced by IL12Bpro polymorphism. |
| Keywords |
IL-12p40, IL-23, IL12B, Promoter polymorphism |
| Adress and Contact Informations |
Department of Molecular Biology, Immunology & Genetics, Faculty of
Medicine, Trakia University, Armeiska 11 St., 6000 Stara Zagora, Bulgaria
* Author for correspondence. e-mail: zdobreva@mf.uni-sz.bg, tel.: +359-42-600-675,
fax: +359-42-600-705 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0025-1 Volume 14 (2009) pp 622-635 |
| Title |
THE IMMUNOSUPPRESSIVE ACTIVITIES OF NEWLY
SYNTHESIZED AZAPHENOTHIAZINES IN HUMAN AND MOUSE
MODELS |
| Authors |
Micha³ Zimecki1, Jolanta Artym1, Maja Kociêba1, Krystian Pluta2*, Beata Morak-M³odawska2 and Ma³gorzata Jeleñ2
|
| Abstract |
In this study, we evaluated the activities of new types of
azaphenothiazines in the following immunological assays: the proliferative
response of human peripheral blood mononuclear cells induced by
phytohemagglutinin A or anti-CD3 antibodies; lipopolysaccharide-induced
cytokine production by human PBMC; the secondary, humoral immune response
in mice to sheep erythrocytes (in vitro); and delayed-type hypersensitivity in
mice to ovalbumin (in vivo). In some tests, chlorpromazine served as a reference
drug. The compounds exhibited differential inhibitory activities in the
proliferation tests, with 10H-2,7-diazaphenothiazine (compound 1) and
6-(3-dimethylaminopropyl)diquinothiazine (compound 8) being most
suppressive. Compound 1 was selected for further studies, and was found to be strongly suppressive in the humoral immune response even at low
concentrations (1 µg/ml). Compound 1 also inhibited the delayed-type
hypersensitivity lipopolysaccharide-induced production of tumor necrosis factor
and interleukin-6 in cultures of human blood cells. As there were only two
subjects in this study, the effects of these compounds on human blood cells need
to be confirmed. In this paper, we also discuss the structure-activity relationships
of selected compounds. |
| Keywords |
Azaphenothiazines, Immune response, PBMC, Proliferation,
Cytokines |
| Adress and Contact Informations |
1Institute of Immunology and Experimental Therapy, Polish Academy of
Sciences, Department of Experimental Therapy, R. Weigla 12, 53-114 Wroc³aw,
Poland,
2The Medical University of Silesia, Department of Organic Chemistry,
Jagielloñska 4, 41-200 Sosnowiec, Poland
* Author for correspondence. e-mail: pluta@sum.edu.pl, fax: (+48 32) 266 78 60 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0018-0 Volume 14 (2009) pp 636-656 |
| Title |
MECHANISMS FOR THE FORMATION OF MEMBRANOUS
NANOSTRUCTURES IN CELL-TO-CELL COMMUNICATION
#
|
| Authors |
Karin Schara1,2, Vid Jansa1, Vid Sustar1, Drago Dolinar1,2, Janez Ivan Pavlic3,4, Marusa Lokar4, Veronika Kralj-Iglic1, Peter Veranic5 and Ales Iglic4* |
| Abstract |
Cells interact by exchanging material and information. Two methods
of cell-to-cell communication are by means of microvesicles and by means of
nanotubes. Both microvesicles and nanotubes derive from the cell membrane
and are able to transport the contents of the inner solution. In this review, we
describe two physical mechanisms involved in the formation of microvesicles
and nanotubes: curvature-mediated lateral redistribution of membrane
components with the formation of membrane nanodomains; and plasma-
mediated attractive forces between membranes. These mechanisms are clinically
relevant since they can be affected by drugs. In particular, the underlying
mechanism of heparin’s role as an anticoagulant and tumor suppressor is the
suppression of microvesicluation due to plasma-mediated attractive interaction
between membranes. |
| Keywords |
Membrane nanostructures, Cell-to-cell communication, Microvesicles,
Nanotubes, Trousseau syndrome, Heparin |
| Adress and Contact Informations |
1Laboratory of Clinical Biophysics, Institute of Biophysics, Faculty of Medicine, University of Ljubljana, Lipičeva 2, SI-1000 Ljubljana, Slovenia,
2University Medical Centre Ljubljana, Zaloška 9, SI-1000 Ljubljana, Slovenia,
3Faculty of Health Studies, University of Ljubljana, Poljanska 26a, SI-1000 Ljubljana, Slovenia,
4Laboratory of Physics, Faculty of Electrical Engineering, University of Ljubljana, Tržaška 25, SI-1000 Ljubljana, Slovenia,
5Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Lipičeva 2, SI-1000 Ljubljana, Slovenia
# The content of this Review was first presented in a shortened form at the 12th Mejbaum-Katzenellenbogen Seminar “Membrane Skeleton. Recent Advances and Future Research Directions”, June 15-18, 2008, Zakopane, Poland. Publication cost was partially covered by the organizers of this meeting.
* Author for correspondence. e-mail: ales.iglic@fe.uni-lj.si, tel.: +386 1 4768 825 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0024-2 Volume 14 (2009) pp 657-669 |
| Title |
ARGININE METHYLATION ANALYSIS OF THE SPLICING-
ASSOCIATED SR PROTEIN SFRS9/SRP30C |
| Authors |
Gustavo C. Bressan1,2, Eduardo C. Moraes1,2, Adriana O. Manfiolli3, Tais M. Kuniyoshi1, Dario O. Passos1,2, Marcelo D. Gomes3 and Jorg Kobarg1,2* |
| Abstract |
The human SFRS9/SRp30c belongs to the SR family of splicing
regulators. Despite evidence that members of this protein family may be targeted
by arginine methylation, this has yet to be experimentally addressed. In this
study, we found that SFRS9 is a target for PRMT1-mediated arginine
methylation in vitro, and that it is immunoprecipitated from HEK-293 lysates by
antibodies that recognize both mono- and dimethylated arginines. We further
observed that upon treatment with the methylation inhibitor Adox, the
fluorescent EGFP-SFRS9 re-localizes to dot-like structures in the cell nucleus.
In subsequent confocal analyses, we found that EGFP-SFRS9 localizes to
nucleoli in Adox-treated cells. Our findings indicate the importance of arginine
methylation for the subnuclear localization of SFRS9. |
| Keywords |
Nuclear bodies, Speckles, RGG boxes, Arginine methylation,
Protein-protein interaction |
| Adress and Contact Informations |
1Laboratório Nacional de Luz Síncrotron, Campinas, SP, Brasil,
2Instituto de Biologia, Universidade Estadual de Campinas, Campinas, SP, Brasil,
3Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brasil
* Author for correspondence: Jörg Kobarg, Laboratório Nacional de Luz Síncrotron, Centro de Biologia Molecular Estrutural, Rua Giuseppe Máximo Scolfaro 10.000, C.P. 6192, 13084-971 Campinas - SP, Brasil, e-mail: jkobarg@lnls.br, tel.: (+55) 19-3512-1125, fax: (+55) 19-3512-1006 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0027-z Volume 14 (2009) pp 670-678 |
| Title |
OVEREXPRESSION OF HUMAN OSTEOPONTIN INCREASES
CELL PROLIFERATION AND MIGRATION IN HUMAN EMBRYO
KIDNEY-293 CELLS |
| Authors |
Ya-Jun Liu1*, Dao-Qiang Zhang2, Xiu-Mei Sui2 and Wei Tian1* |
| Abstract |
Malignant tumors are characterized by dysregulated cell growth and
the metastasis of secondary tumors. Numerous studies have documented that
osteopontin (OPN) plays a key role in regulating tumor progression and
metastasis. Here, we show that the overexpression of OPN in human embryo
kidney-293 cells significantly increases both the level of cell proliferation, by
provoking the G1/S transition, and the level of cell migration in vitro. These
findings suggest that augmented OPN contributes to cell growth and motility.
Inhibiting OPN or the pathway it stimulates may therefore represent a novel
approach for the treatment of primary tumors and associated metastases. |
| Keywords |
Osteopontin, Overexpression, Proliferation, Metastasis |
| Adress and Contact Informations |
1Beijing Jishuitan Hospital, Peking University, Beijing 100035, P. R. China
2Wendeng Central Hospital, Weifang Medical College, Weihai, Shandong Province 264400, P. R. China
* Author for correspondence. Ya-Jun Liu, e-mail: yajun.liu001@gmail.com and Wei Tian, tianweia@163bj.com |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0026-0 Volume 14 (2009) pp 679-691 |
| Title |
THE TRANSCRIPTIONAL REGULATION OF PODOCIN (NPHS2) BY
Lmx1b AND A PROMOTER SINGLE NUCLEOTIDE POLYMORPHISM |
| Authors |
Sigrid Harendza*, Rolf A.K. Stahl and Andre Schneider |
| Abstract |
Podocin (NPHS2) is a component of the glomerular slit membrane
with major regulatory functions in the renal permeability of proteins. A loss of
podocin and a decrease in its resynthesis can influence the outcome of renal
diseases with nephrotic syndrome, such as minimal change glomerulonephritis,
focal segmental glomerulosclerosis (FSGS) and membranous nephropathy. The
transcriptional regulation of podocin may play a major role in these processes.
We defined the transcriptional regulation of the human podocin gene and the
influence of single nucleotide polymorphisms (SNPs) within its promoter region
in the podocytes using reporter gene constructs and gel shift analysis. In
addition, we took genomic DNA from healthy Caucasian blood donors and from
biopsies of kidneys with defined renal diseases and screened it for podocin
promoter SNPs. Our data shows that the transcription of podocin is mainly
regulated by the transcription factor Lmx1b, which binds to a FLAT-F element
and displays enhancer function. With the SNP variant -116T, there was
a significant reduction in luciferase activity, and nuclear protein binding was
observed, while the SNP -670C/T did not display functionality. The allelic
distribution of -116C/T in patients with kidney diseases leading to nephrotic
syndrome was not significantly different from that in the control group. Our data
indicates that among other factors, podocin is specifically regulated by the
transcription factor Lmx1b and by the functional polymorphism -116C/T.
However, there is no association between -116C/T and susceptibility to minimal
change glomerulonephritis, focal segmental glomerulosclerosis or membranous
nephropathy. |
| Keywords |
Lmx1b, Nephrotic syndrome, NPHS2 gene, Podocin promoter,
Proteinuria, SNP, Transcription |
| Adress and Contact Informations |
Universitätsklinikum Hamburg-Eppendorf, III. Medizinische Klinik, Martinistr. 52,
D-20246 Hamburg, Germany
* Author for correspondence. e-mail: harendza@uke.de, tel.: +4940428033908, fax:
+4940428035186 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0028-y Volume 14 (2009) pp 692-702 |
| Title |
MOLECULAR CHARACTERIZATION OF THE niaD AND pyrG GENES FROM Penicillium camemberti, AND THEIR USE AS TRANSFORMATION MARKERS |
| Authors |
Katherinne Navarrete1, Amanda Roa1, Inmaculada Vaca2, Yeison Espinosa1, Claudio Navarro1 and Renato Chavez1,* |
| Abstract |
Genetic manipulation of the filamentous fungus Penicillium
camemberti has been limited by a lack of suitable genetics tools for this fungus.
In particular, there is no available homologous transformation system. In this
study, the nitrate reductase (niaD) and orotidine-5’-monophosphate
decarboxylase (pyrG) genes from Penicillium camemberti were characterized,
and their suitability as metabolic molecular markers for transformation was
evaluated. The genes were amplified using PCR-related techniques, and
sequenced. The niaD gene is flanked by the nitrite reductase (niiA) gene in
a divergent arrangement, being part of the putative nitrate assimilation cluster in
P. camemberti. pyrG presents several polymorphisms compared with
a previously sequenced pyrG gene from another P. camemberti strain, but almost
all are silent mutations. Southern blot assays indicate that one copy of each gene
is present in P. camemberti. Northern blot assays showed that the pyrG gene is
expressed in minimal and rich media, and the niaD gene is expressed in nitrate,
but not in reduced nitrogen sources. The functionality of the two genes as
transformation markers was established by transforming A. nidulans pyrG- and
niaD-deficient strains. Higher transformation efficiencies were obtained with a pyrG-containing plasmid. This is the first study yielding a molecular and
functional characterization of P. camemberti genes that would be useful as
molecular markers for transformation, opening the way for the future
development of a non-antibiotic genetic transformation system for this fungus. |
| Keywords |
Penicillium camemberti, niaD gene, pyrG gene, Transformation,
Aspergillus nidulans |
| Adress and Contact Informations |
1Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile (USACH), Alameda 3363, Estación Central 9170022, Santiago, Chile,
2Departamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Ñuñoa, Santiago, Chilel
* Author for correspondence. e-mail: renato.chavez@usach.cl, tel.: +56-2-7181091, fax: +56-2-6812108 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
| DOI: 10.2478/s11658-009-0029-x Volume 14 (2009) pp 703-714 |
| Title |
INCREASED EXPRESSION OF PAD2 AFTER REPEATED INTRACEREBROVENTRICULAR INFUSIONS OF SOLUBLE Aβ25-35 IN THE ALZHEIMER’S DISEASE MODEL RAT BRAIN: EFFECT OF MEMANTINE |
| Authors |
Mohammad Arif1,2* and Takeshi Kato1 |
| Abstract |
Peptidylarginine deiminases (PADs) convert the arginine residues in
proteins into citrulline residues in a Ca
2+
-dependent manner. We previously
showed that a bilateral injection of ibotenic acid into the rat nucleus basalis
magnocellularis elevated the PAD2 activity in the hippocampus and striatum. In
this study, we examined whether repeated intracerebroventricular infusions of
soluble Aβ25-35 would affect the PAD2 expression in any regions of the rat brain.
We also assessed the protective effect of memantine on Aβ-induced PAD2
alterations. The infusion of Aβ25-35 increased the activity and protein level of
PAD2 in the hippocampus, and co-treatment with memantine suppressed these
changes. An immunohistochemical analysis showed that an increased level of
PAD2 was coincident with GFAP-positive astrocytes and CD11b-positive
microglia. In addition, immunofluoresecence staining revealed that citrulline-
postive immunoreactivity coincided with the occurrence of GFAP-positive
astrocytes. Co-treatment with memantine reversed the activation of the
astrocytes and microglia, thus attenuating the PAD2 increment. These
biochemical and immunohistochemical results suggest that PAD2 might play an
important role in the pathology of early Alzheimer’s disease, and may correlate
with the changes in glial cells that are recovered by memantine treatment. |
| Keywords |
Peptidylarginine deiminase, Alzheimer’s disease, Astrocytes,
Microglia, Memantine |
| Adress and Contact Informations |
1Graduate School of Integrated Science, Yokohama City University, 22-2 Seto, Kanazawa-ku, Yokohama 236-0027, Japan,
2Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka-1000, Bangladesh
* Author for correspondence. e-mail: marif@univdhaka.edu; marif567@yahoo.com, tel.: 880-2-9661920-59, ext: 7643, fax: 880-2-8615583 |
![[Rozmiar: 1332 bajtów]](pic/abstract.gif) |
|
Office:
Cellular & Molecular Biology Letters
Faculty of Biotechnology
University of Wroc³aw
Przybyszewskiego 63/77
51-148 Wroc³aw, Poland
fax:
+48 71 375 6208 or
+48 71 375 6234
e-mail:
cmbl@cmbl.org.pl or
cmbl@ibmb.uni.wroc.pl
|